|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 35477 |
FusionGeneSummary for SP100_SUCLG1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SP100_SUCLG1 | Fusion gene ID: 35477 | Hgene | Tgene | Gene symbol | SP100 | SUCLG1 | Gene ID | 6672 | 8802 |
| Gene name | SP100 nuclear antigen | succinate-CoA ligase alpha subunit | |
| Synonyms | lysp100b | GALPHA|MTDPS9|SUCLA1 | |
| Cytomap | 2q37.1 | 2p11.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | nuclear autoantigen Sp-100SP100-HMG nuclear autoantigennuclear dot-associated Sp100 proteinspeckled 100 kDa | succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrialSCS-alphasuccinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrialsuccinyl-CoA ligase [GDP-forming] subunit alpha, mitochondrialsuccinyl-CoA synthetase subunit alpha | |
| Modification date | 20180522 | 20180523 | |
| UniProtAcc | P23497 | P53597 | |
| Ensembl transtripts involved in fusion gene | ENST00000264052, ENST00000409112, ENST00000340126, ENST00000427101, ENST00000409824, ENST00000409341, ENST00000341950, ENST00000409897, | ENST00000393868, ENST00000491123, | |
| Fusion gene scores | * DoF score | 4 X 4 X 2=32 | 2 X 2 X 1=4 |
| # samples | 4 | 3 | |
| ** MAII score | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(3/4*10)=2.90689059560852 | |
| Context | PubMed: SP100 [Title/Abstract] AND SUCLG1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | SP100 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 15247905 |
| Hgene | SP100 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 14647468 |
| Hgene | SP100 | GO:0034340 | response to type I interferon | 9230084|15247905 |
| Hgene | SP100 | GO:0034341 | response to interferon-gamma | 9230084 |
| Hgene | SP100 | GO:0043392 | negative regulation of DNA binding | 15247905 |
| Hgene | SP100 | GO:0043433 | negative regulation of DNA binding transcription factor activity | 15247905 |
| Hgene | SP100 | GO:0045185 | maintenance of protein location | 12470659 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BP319935 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-3UTR | ENST00000264052 | ENST00000393868 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-5UTR | ENST00000264052 | ENST00000491123 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-3UTR | ENST00000409112 | ENST00000393868 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-5UTR | ENST00000409112 | ENST00000491123 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-3UTR | ENST00000340126 | ENST00000393868 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-5UTR | ENST00000340126 | ENST00000491123 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-3UTR | ENST00000427101 | ENST00000393868 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-5UTR | ENST00000427101 | ENST00000491123 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-3UTR | ENST00000409824 | ENST00000393868 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-5UTR | ENST00000409824 | ENST00000491123 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-3UTR | ENST00000409341 | ENST00000393868 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-5UTR | ENST00000409341 | ENST00000491123 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-3UTR | ENST00000341950 | ENST00000393868 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-5UTR | ENST00000341950 | ENST00000491123 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-3UTR | ENST00000409897 | ENST00000393868 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
| 5CDS-5UTR | ENST00000409897 | ENST00000491123 | SP100 | chr2 | 231307732 | + | SUCLG1 | chr2 | 84650733 | - |
Top |
FusionProtFeatures for SP100_SUCLG1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| SP100 | SUCLG1 |
| Succinyl-CoA synthetase functions in the citric acidcycle (TCA), coupling the hydrolysis of succinyl-CoA to thesynthesis of either ATP or GTP and thus represents the only stepof substrate-level phosphorylation in the TCA. The alpha subunitof the enzyme binds the substrates coenzyme A and phosphate, whilesuccinate binding and specificity for either ATP or GTP isprovided by different beta subunits. {ECO:0000255|HAMAP-Rule:MF_03222}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SP100_SUCLG1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SP100_SUCLG1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SP100_SUCLG1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SP100_SUCLG1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | SUCLG1 | C3151476 | MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA) | 3 | CTD_human;ORPHANET;UNIPROT |
| Tgene | SUCLG1 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|